New York, NY -- (SBWIRE) -- 04/30/2021 -- Blood Screening Market Size – USD 1.87 Billion in 2019, Market Growth - CAGR of 12.7%, Market trends – Growing prevalence of new pathogens.

The global Blood Screening Market is forecast to reach USD 4.86 Billion by 2027, according to a new report by Reports and Data. The primary driving factors for the growth of the blood screening market is an increase in the prevalence of infectious diseases, rise in healthcare awareness, growth in the number of blood donations, and surge in NAT (nucleic acid amplification test).

Moreover, support from the government for a better healthcare system and advancement in technology will propel the growth of the market. However, factors such as stringent regulatory approvals and lack of skilled professionals are hampering the industry's demand.

Various factors are promoting the growth and demand for blood screening. One of these contributing factors is an increase in the rate of technological advancements in the healthcare industry. An increase in the demand for technologically advanced methods in context to sample extraction, preparation, testing, and amplification for nucleic acid-like RNA and DNA along with strategic agreements with manufacturers of renowned research institutions are promoting research activities, which is forecasted to have a positive impact on the market.

Request a Sample Copy of the Research Report @ https://www.reportsanddata.com/sample-enquiry-form/3458

Leading Players Profiled in the Report Include:

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Ortho-Clinical Diagnostics, Inc., Grifols, Siemens Healthcare GmbH, SOFINA S.A, and Thermo Fisher Scientific, Inc., among others.

North America accounted for the leading market share, owing to the increased prominence of blood tests, along with a large number of R&D activities taking place in the region. Presence of well-established and equipped health care organizations, government efforts in promoting the use of disposable blood bags, and constantly developing sterility aspects are some of the factors that would further fuel growth in the region.

The COVID-19 impact:

The market will witness a huge surge as biopharmaceutical innovators are in the front line for the human response to the global COVID-19 pandemic. A significant number of biotech firms are in the middle of the race to investigate the virus's genome and are preparing a viable vaccine. These companies are investigating the virus at an unprecedented rate, and considerable funds are being put into the research. The companies are in trial, and the public and private sectors are working continuously for the development of the vaccine. There is a huge demand for testing kits for the diagnosis of Sars-Cov-2, which will foster the demand for the market.

Further key findings from the report suggest

The reagent and kits segment held a significant share owing to the accessibility of a wide range of reagents and the need for specific, reliable, and fast detection of blood screening. The growing demand for blood transfusion for the treatment of blood disorders contributed to the demand of the industry.

Nucleic acid testing (NAT) is a kind of molecular method deployed for in cases such as blood donations to screen the blood so as to decrease the danger of TTIs (transfusion-transmitted infections) in the individual receiving the blood. The main application of the nucleic acid test is associated with detecting viral RNAs and DNAs in a blood sample.

Hospitals held a larger market share due to the high number of cases recorded there. The segment is forecasted to grow with a CAGR of xx% during the forecast period.

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/3458

For the purpose of this report, Reports and Data have segmented the global Blood Screening Market on the basis of Product and Services, Technology, End-User, and region:

Product and Services Outlook (Revenue, USD Billion; 2017-2027)

Reagents and Kits
NAT Reagents and Kits
Standards and Controls
Buffers, Nucleotides, and Solutions
Enzymes and Polymerases
Probes and Primers
Labeling and Detection Reagents
ELISA Reagents and Kits
Controls
Substrates
Immunosorbents
Conjugates
Sample Diluents and Wash Solutions
Instruments
Rental Purchase
Outright Purchase
Software and Services

Technology Outlook (Revenue, USD Billion; 2017-2027)

ELISA
Fluorescent immunoassay
Chemiluminescent Immunoassay
Colorimetric Immunoassay
NAT
Transcription-Mediated Amplification
Real-time Polymerase Chain Reaction
Western Blot Assays
Rapid Tests
NGS

End-User Outlook (Revenue, USD Billion; 2017-2027)

Hospitals
Blood Banks

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
U.S
Canada
Europe
Germany
U.K
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA

Request for Customization @ https://www.reportsanddata.com/request-customization-form/3458

Table of contents           

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Blood Screening Market Segmentation & Impact Analysis

    4.1. Blood Screening Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Increasing demand for donated blood and rising number of blood donations

                    4.2.2.2. Rising prevalence of infectious diseases

          4.2.3. Market restraints analysis

                    4.2.3.1. High Cost

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. ETOP Analysis

    4.6. Porter's Five Forces Analysis

    4.7. Competitive Metric Space Analysis

    4.8. Price trend Analysis

    4.9. Customer Mapping

    4.10. Covid-19 Impact Analysis

    4.11. Global Recession Influence

Continued…………….

Have Any Query? Ask Our Experts @ https://www.reportsanddata.com/speak-to-analyst-form/3458

About Reports and Data                              
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.